|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor
|
|
Ch. 17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13-1117.
(A) THERE IS A STATEWIDE ACADEMIC HEALTH CENTER COMPONENT IN THE
PROGRAM.
(B) THE PURPOSE OF THE STATEWIDE ACADEMIC HEALTH CENTER
COMPONENT IS TO MAXIMIZE THE EFFECTIVENESS OF STATEWIDE ANTICANCER
INITIATIVES IN THE STATE.
(C) THE DEPARTMENT MAY DISTRIBUTE A STATEWIDE ACADEMIC HEALTH
CENTER GRANT TO THE UNIVERSITY OF MARYLAND MEDICAL SYSTEM GROUP AND
THE JOHNS HOPKINS CROUP INSTITUTIONS TO FUND INITIATIVES TO REDUCE
CANCER MORBIDITY AND MORTALITY IN THE STATE.
(D) THE UNIVERSITY OF MARYLAND MEDICAL SYSTEM CROUP AND THE
JOHNS HOPKINS GROUP INSTITUTIONS MAY EACH APPLY FOR A STATEWIDE
ACADEMIC HEALTH CENTER GRANT FOR THE PURPOSES ESTABLISHED IN §§ 13-1111
13-1118 AND 13-1112 13-1119 OF THIS SUBTITLE.
(E) THE AMOUNT OF A STATEWIDE ACADEMIC HEALTH CENTER GRANT THAT
IS DISTRIBUTED TO THE UNIVERSITY OF MARYLAND MEDICAL SYSTEM GROUP OR
THE JOHNS HOPKINS GROUP INSTITUTIONS SHALL BE EQUAL TO THE AMOUNT
ALLOCATED IN THE STATE BUDGET.
(F) THE DEPARTMENT SHALL ANNUALLY EVALUATE THE EFFICIENCY AND
EFFECTIVENESS OF INITIATIVES FUNDED BY A STATEWIDE ACADEMIC HEALTH
CENTER GRANT.
(G) THE UNIVERSITY OF MARYLAND MEDICAL GROUP AND THE JOHNS
HOPKINS INSTITUTIONS SHALL COORDINATE INITIATIVES TO MAXIMIZE THE USE OF
THE FUNDS AND TO ELIMINATE UNNECESSARY DUPLICATION OF EFFORTS.
13-1111. 13-1118.
(A) THE DEPARTMENT MAY DISTRIBUTE, AND THE UNIVERSITY OF
MARYLAND MEDICAL SYSTEM GROUP MAY APPLY FOR, A STATEWIDE ACADEMIC
HEALTH CENTER GRANT TO FUND;
(1) ESTABLISHMENT OF THE TELEMEDICINE MARYLAND TELEMEDICINE
NETWORK RELATING TO TARGETED CANCERS;
(2) PREVENTION, IDENTIFICATION, AND TREATMENT OF TARGETED
CANCERS THROUGH THE TELEMEDICINE MARYLAND TELEMEDICINE NETWORK;
(3) TRANSLATIONS RESEARCH ACTIVITIES RELATING TO TARGETED
CANCERS WITH A COAL OF INCREASING THE RATE AT WHICH CANCER RESEARCH
ACTIVITIES ARE TRANSLATED INTO TREATMENT PROTOCOLS IN THE STATE;
(4) CLINICAL RESEARCH ACTIVITIES THAT MAY LEAD TO A CURE FOR A
TARGETED CANCER; AND
(5) RENOVATION, EXPANSION, AND EQUIPPING OF CRITICAL RESEARCH
LABORATORIES AND CLINICAL FACILITIES; AND
|
|
|
|
|
|
|
|
|
|
- 229 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
